Valuation: Revvity, Inc.

Market Cap 16.84B 85.15B 15.01B 13.91B 12.65B 23.73B 1,597B 24.12B 167B 65.6B 835B 63.19B 61.87B 2,668B P/E 2026 *
63.6x
P/E 2027 * 50.1x
Enterprise Value 18.83B 95.19B 16.78B 15.55B 14.14B 26.53B 1,785B 26.96B 186B 73.33B 933B 70.64B 69.16B 2,983B EV / Sales 2026 *
6.6x
EV / Sales 2027 * 6.08x
Free-Float
99.74%
Yield 2026 *
0.19%
Yield 2027 * 0.18%
1 day+33.98%
Current month+33.98%
1 month+33.98%
3 months+38.00%
6 months+66.57%
Current year+47.59%
1 month 27.47
Extreme 27.47
27.75
Current year 14.91
Extreme 14.91
27.75
1 year 14.91
Extreme 14.91
27.75
3 years 14.51
Extreme 14.51
27.75
5 years 14.51
Extreme 14.51
39.55
10 years 11.96
Extreme 11.957142
39.55
Manager TitleAgeSince
Chief Executive Officer 61 29/12/2019
Director of Finance/CFO 37 05/09/2022
Chief Tech/Sci/R&D Officer - 30/04/2023
Director TitleAgeSince
Chairman 68 29/12/2019
Director/Board Member 74 06/02/2012
Director/Board Member 72 26/07/2016
Change 5-day change 1-year change 3-year change Capi.($)
+33.98%0.00% - - 17.03B
-1.54%+2.59%+26.06%+44.65% 255B
-2.01%+1.46%+7.35%+8.26% 161B
+1.52%+1.30%-2.90%+58.41% 151B
+1.49%+2.76%-54.60%-10.88% 64.33B
-1.01%+3.53%-14.13%-10.86% 51.9B
+2.08%+7.08%+11.66%+56.70% 50.25B
+0.72%+0.96%+16.85%+26.26% 49.92B
-1.77%-0.83%+19.72%+55.15% 48.77B
-0.61%+0.50%+29.79%+72.10% 42.93B
Average +3.11%+2.10%+4.42%+33.31% 97.22B
Weighted average by Cap. -0.10%+2.53%+7.79%+34.52%

Financials

2026 *2027 *
Net sales 2.85B 14.42B 2.54B 2.36B 2.14B 4.02B 270B 4.08B 28.25B 11.11B 141B 10.7B 10.48B 452B 3.01B 15.21B 2.68B 2.48B 2.26B 4.24B 285B 4.31B 29.79B 11.71B 149B 11.28B 11.05B 476B
Net income 274M 1.38B 244M 226M 205M 386M 25.95B 392M 2.71B 1.07B 13.56B 1.03B 1.01B 43.35B 346M 1.75B 309M 286M 260M 488M 32.82B 496M 3.43B 1.35B 17.15B 1.3B 1.27B 54.84B
Net Debt 1.99B 10.04B 1.77B 1.64B 1.49B 2.8B 188B 2.84B 19.66B 7.73B 98.38B 7.45B 7.29B 314B 1.46B 7.37B 1.3B 1.2B 1.09B 2.05B 138B 2.09B 14.44B 5.68B 72.26B 5.47B 5.36B 231B
Projected Income Statement - Annual - Revvity, Inc.
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Revvity, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
150.94USD
Average target price
147.53USD
Spread / Average Target
-2.26%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Revvity, Inc.